Current and historical daily PE Ratio for Atreca Inc (
FRA:0C1
) from 2019 to Jun 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Atreca stock (FRA:0C1) PE ratio as of Jun 01 2024 is 0.
More Details
Atreca Inc (FRA:0C1) PE Ratio (TTM) Chart
Atreca Inc (FRA:0C1) PE Ratio (TTM) Historical Data
View and export this data going back to 2019. Start your Free Trial
Total 1232
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Atreca PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-01 | At Loss | 2024-01-26 | At Loss |
| 2024-03-28 | At Loss | 2024-01-25 | At Loss |
| 2024-03-27 | At Loss | 2024-01-24 | At Loss |
| 2024-03-26 | At Loss | 2024-01-23 | At Loss |
| 2024-03-25 | At Loss | 2024-01-22 | At Loss |
| 2024-03-22 | At Loss | 2024-01-19 | At Loss |
| 2024-03-21 | At Loss | 2024-01-18 | At Loss |
| 2024-03-20 | At Loss | 2024-01-17 | At Loss |
| 2024-03-19 | At Loss | 2024-01-16 | At Loss |
| 2024-03-18 | At Loss | 2024-01-12 | At Loss |
| 2024-03-15 | At Loss | 2024-01-11 | At Loss |
| 2024-03-14 | At Loss | 2024-01-10 | At Loss |
| 2024-03-13 | At Loss | 2024-01-09 | At Loss |
| 2024-03-12 | At Loss | 2024-01-08 | At Loss |
| 2024-03-11 | At Loss | 2024-01-05 | At Loss |
| 2024-03-08 | At Loss | 2024-01-04 | At Loss |
| 2024-03-07 | At Loss | 2024-01-03 | At Loss |
| 2024-03-06 | At Loss | 2024-01-02 | At Loss |
| 2024-03-05 | At Loss | 2023-12-29 | At Loss |
| 2024-03-04 | At Loss | 2023-12-28 | At Loss |
| 2024-03-01 | At Loss | 2023-12-27 | At Loss |
| 2024-02-29 | At Loss | 2023-12-22 | At Loss |
| 2024-02-28 | At Loss | 2023-12-21 | At Loss |
| 2024-02-27 | At Loss | 2023-12-20 | At Loss |
| 2024-02-26 | At Loss | 2023-12-19 | At Loss |
| 2024-02-23 | At Loss | 2023-12-18 | At Loss |
| 2024-02-22 | At Loss | 2023-12-15 | At Loss |
| 2024-02-21 | At Loss | 2023-12-14 | At Loss |
| 2024-02-20 | At Loss | 2023-12-13 | At Loss |
| 2024-02-19 | At Loss | 2023-12-12 | At Loss |
| 2024-02-16 | At Loss | 2023-12-11 | At Loss |
| 2024-02-15 | At Loss | 2023-12-08 | At Loss |
| 2024-02-14 | At Loss | 2023-12-07 | At Loss |
| 2024-02-13 | At Loss | 2023-12-06 | At Loss |
| 2024-02-12 | At Loss | 2023-12-05 | At Loss |
| 2024-02-09 | At Loss | 2023-12-04 | At Loss |
| 2024-02-08 | At Loss | 2023-12-01 | At Loss |
| 2024-02-07 | At Loss | 2023-11-30 | At Loss |
| 2024-02-06 | At Loss | 2023-11-29 | At Loss |
| 2024-02-05 | At Loss | 2023-11-28 | At Loss |
| 2024-02-02 | At Loss | 2023-11-27 | At Loss |
| 2024-02-01 | At Loss | 2023-11-24 | At Loss |
| 2024-01-31 | At Loss | 2023-11-23 | At Loss |
| 2024-01-30 | At Loss | 2023-11-22 | At Loss |
| 2024-01-29 | At Loss | 2023-11-21 | At Loss |
Atreca Inc (FRA:0C1) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Atreca Inc
NAICS : 325412
SIC : 2834
ISIN : US04965G1094
Share Class Description:
FRA:0C1: Class ADescription
Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. It has single segment business of therapeutic drug discovery and development. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers